Evidence map›Paper›PMID 33251246›Full record

ArticleFrontiers in molecular biosciences2020

Short Read Alignment Based on Maximal Approximate Match Seeds.

Wei Quan, Dengfeng Guan, Guangri Quan, Bo Liu, Yadong Wang

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei QuanSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Dengfeng GuanSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Guangri QuanSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Bo LiuSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Yadong WangSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequence alignment is a critical step in many critical genomic studies, such as variant calling, quantitative transcriptome analysis (RNA-seq), and metagenomic sequence classification. However, the alignment performance is largely affected by repetitive sequences in the reference genome, which extensively exist in species from bacteria to mammals. Aligning repeating sequences might lead to tremendous candidate locations, bringing about a challenging computational burden. Thus, most alignment tools prefer to simply discard highly repetitive seeds, but this may cause the true alignment to be missed. Using maximal approximate matches (MAMs) as seeds is an option, but MEMs seeds may fail due to sequencing errors or genomic variations in MEMs seeds. Here, we propose a novel sequence alignment algorithm, named MAM, which can efficiently align short DNA sequences. MAM first builds a modified Burrows-Wheeler transform (BWT) structure of a reference genome to accelerate approximate seed matching. Then, MAM uses maximal approximate matches (MAMs) seeds to reduce the candidate locations. Finally, MAM applies an affine-gap-penalty dynamic programming to extend MAMs seeds. Experimental results on simulated and real sequencing datasets show that MAM achieves better performance in speed than other state-of-the-art alignment tools. The source code is available at https://github.com/weiquan/mam.

Indexed as

FM-indexnext-generation sequencingrepeatssequence alignmentwhole-genome resequencing

Identifiers

PMID33251246
PMCPMC7674947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.